A Case of Pyoderma Gangrenosum of the Face Associated with Ulcerative Colitis

被引:0
作者
Kim, Eun Sil [1 ]
Seo, Min Ho [1 ]
Choi, Hyuk Soon [1 ]
Keum, Bora [1 ]
Seo, Yeon Seok [1 ]
Kim, Yong Sik [1 ]
Jeen, Yoon Tae [1 ]
Lee, Hong Sik [1 ]
Chun, Hoon Jai [1 ]
Um, Soon Ho [1 ]
Kim, Chang Duck [1 ]
Ryu, Ho Sang [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Colitis; Ulcerative; Skin Manifestations; Pyoderma Gangrenosum;
D O I
10.5217/ir.2011.9.3.225
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ulcerative colitis is associated with various extra-intestinal manifestations, including rheumatic, dermatologic, ophthalmologic, biliary, and hematologic manifestations. Cutaneous findings are common extra-intestinal manifestations of ulcerative colitis, occurring in 10-20% of patients. Cutaneous manifestations include erythema nodosum, pyoderma gangrenosum, aphthous stomatitis, and acute febrile neutrophilic dermatosis. Treatments for these cutaneous manifestations include corticosteroids, cyclosporine, tacrolimus, mycophenolate mofetil, azathioprine, and infliximab. A 48-year-old male presented with an acute exacerbation of ulcerative colitis associated with multiple skin lesions on his face, thumbs, thighs, and feet. The final impression was neutrophilic folliculitis, which is an early form of pyoderma gangrenosum. The patient's skin lesions and colitis both improved with corticosteroids. There are rare published case reports of ulcerative colitis exacerbations associated with pyoderma gangrenosum that initiated as neutrophilic folliculitis of the face. This case report includes a review of the literature.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 19 条
[1]   Pyoderma gangrenosum: uncommon presentations [J].
Ahmadi, S ;
Powell, FC .
CLINICS IN DERMATOLOGY, 2005, 23 (06) :612-620
[2]   Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology [J].
Baumgart, Daniel C. ;
Carding, Simon R. .
LANCET, 2007, 369 (9573) :1627-1640
[3]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[4]   Pyoderma gangrenosum [J].
Callen, JP .
LANCET, 1998, 351 (9102) :581-585
[5]   Topical tacrolimus therapy for pyoderma gangrenosum [J].
Chiba, T ;
Isomura, I ;
Suzuki, A ;
Morita, A .
JOURNAL OF DERMATOLOGY, 2005, 32 (03) :199-203
[6]   Extraintestinal manifestations in inflammatory bowel disease [J].
Danese, Silvio ;
Semeraro, Stefano ;
Papa, Alfredo ;
Roberto, Italia ;
Scaldaferri, Franco ;
Fedeli, Giuseppe ;
Gasbarrini, Giovanni ;
Gasbarrini, Antonio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (46) :7227-7236
[7]   Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management [J].
Larsen, Signe ;
Bendtzen, Klaus ;
Nielsen, Ole Haagen .
ANNALS OF MEDICINE, 2010, 42 (02) :97-114
[8]   TREATMENT OF PYODERMA-GANGRENOSUM WITH CYCLOSPORINE [J].
MATIS, WL ;
ELLIS, CN ;
GRIFFITHS, CEM ;
LAZARUS, GS .
ARCHIVES OF DERMATOLOGY, 1992, 128 (08) :1060-1064
[9]  
Menachem Y, 2004, ISRAEL MED ASSOC J, V6, P88
[10]   Pyoderma gangrenosum: Classification and management [J].
Powell, FC ;
Su, WPD ;
Perry, HO .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (03) :395-409